FOURTH STOCK OPTION AGREEMENTFourth Stock Option Agreement • March 13th, 2017 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products • Nevada
Contract Type FiledMarch 13th, 2017 Company Industry JurisdictionThis Fourth Stock Option Agreement (“Agreement”) is made as of the 10th day of March, 2017 by and between PharmaCyte Biotech, Inc. (“Company”) and Gerald W. Crabtree (“Participant”).
FOURTH STOCK OPTION AGREEMENTFourth Stock Option Agreement • March 13th, 2017 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products • Nevada
Contract Type FiledMarch 13th, 2017 Company Industry JurisdictionThis Fourth Stock Option Agreement (“Agreement”) is made as of the 10th day of March, 2017 by and between PharmaCyte Biotech, Inc. (“Company”) and Kenneth L. Waggoner (“Participant”).